Fig. 2From: miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimodmiR-548a-3p expression levels in the Discovery and Validation cohort. dCq: delta Cq. Observations below the limit of detection are shown on the graph subtracting 1 to the smallest value. A higher value thus indicates that the microRNA is more abundant in the particular sample. NEDA-3 No Evidence of Disease Activity, EDA-3 Evidence of Disease Activity. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001Back to article page